FOLVITE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Folvite, and when can generic versions of Folvite launch?
Folvite is a drug marketed by Wyeth Pharms Inc and is included in one NDA.
The generic ingredient in FOLVITE is folic acid. There are ten drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the folic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Folvite
A generic version of FOLVITE was approved as folic acid by WATSON LABS on December 31st, 1969.
Summary for FOLVITE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 139 |
Clinical Trials: | 3 |
Patent Applications: | 1,520 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FOLVITE at DailyMed |
Recent Clinical Trials for FOLVITE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Korean Cancer Study Group | Phase 3 |
Asan Medical Center | Phase 3 |
Jawaharlal Institute of Postgraduate Medical Education & Research | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for FOLVITE
US Patents and Regulatory Information for FOLVITE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Pharms Inc | FOLVITE | folic acid | INJECTABLE;INJECTION | 005897-008 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Pharms Inc | FOLVITE | folic acid | TABLET;ORAL | 005897-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |